Add like
Add dislike
Add to saved papers

Inflammatory myofibroblastic tumor of the urinary bladder in a patient with the left renal cell carcinoma: A case report.

This case report describes an inflammatory tumor of the urinary bladder along with left renal cell carcinoma which occurred in a 73-year-old male with a narrowed orificium urethrae internum and severe hyperplasia of the prostate gland. A biopsy was not obtained prior to surgery. An inflammatory myofibroblastic tumor (IMT) of the urinary bladder is a rare benign lesion, particularly in the elderly. To the best of our knowledge, there are no studies concerning IMTs of the urinary bladder in patients with unilateral renal cell carcinoma. A bladder lesion due to an IMT may be easily misdiagnosed as metastasis from left renal cell carcinoma due to the hypervascularity of the tumor. In this case, radical surgery of the cancer of the left kidney was performed by laparoscopy. Subsequently, after three weeks and according to the examination of the intraoperative frozen-sections, a partial cystectomy was performed. Thus, radical resection of the bladder and the associated complications were avoided.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app